Evidence map›Paper›PMID 32555397›Full record

ArticleScientific reports2020

Transient Receptor Potential Vanilloid channel regulates fibroblast differentiation and airway remodeling by modulating redox signals through NADPH Oxidase 4.

Nosayba Al-Azzam, Lakshminarayan Reddy Teegala, Sabita Pokhrel, Samrawit Ghebreigziabher, Tatiana Chachkovskyy, Sathwika Thodeti, Ignacio Gavilanes, Kayla Covington, Charles K Thodeti, Sailaja Paruchuri

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Prostaglandin EFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  8. Association of the Toll-like receptor 4 and NOX4 gene and protein levels in asthmatic patients with metabolic syndrome: A case-control study.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Nosayba Al-AzzamDepartment of Chemistry, University of Akron, Akron, OH, US.
Lakshminarayan Reddy TeegalaDepartment of Chemistry, University of Akron, Akron, OH, US.
Sabita PokhrelDepartment of Chemistry, University of Akron, Akron, OH, US.
Samrawit GhebreigziabherDepartment of Chemistry, University of Akron, Akron, OH, US.
Tatiana ChachkovskyyDepartment of Chemistry, University of Akron, Akron, OH, US.
Sathwika ThodetiDepartment of Chemistry, University of Akron, Akron, OH, US.
Ignacio GavilanesDepartment of Chemistry, University of Akron, Akron, OH, US.
Kayla CovingtonDepartment of Chemistry, University of Akron, Akron, OH, US.
Charles K ThodetiDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, US.
Sailaja ParuchuriDepartment of Chemistry, University of Akron, Akron, OH, US. sp97@uakron.edu.
University of Akron · USNortheast Ohio Medical University · US

Funding

Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast Cell Activation and Pulmonary Inflammation during AsthmaR01AI144115 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI PARUCHURI, SAILAJA · 2019 to 2023
$1.8M
Novel Synergism Between LTD4 and PGE2 Signaling in MC-medicated InflammationR15HL133918 · NHLBI · UNIVERSITY OF AKRON · PI PARUCHURI, SAILAJA · 2016 to 2016
$456k
NHLBI NIH HHS R15 HL133918NIAID NIH HHS R01 AI144115
6 · The paper itself

Abstract

Asthma is characterized by pathological airway remodeling resulting from persistent myofibroblast activation. Although transforming growth factor beta 1 (TGFβ1), mechanical signals, and reactive oxygen species (ROS) are implicated in fibroblast differentiation, their integration is still elusive. We identified that Transient Receptor Potential Vanilloid 4 (TRPV4), a mechanosensitive ion channel mediates lung fibroblast (LF) differentiation and D. farinae-induced airway remodeling via a novel TRPV4-NADPH Oxidase 4 (NOX4) interaction. NOX4-mediated ROS production is essential for TGFβ1-induced LF differentiation via myocardin-related transcription factor-A (MRTF-A) and plasminogen activator inhibitor 1 (PAI-1). Importantly, TRPV4 inhibition prevented TGFβ1-induced NOX4 expression and ROS production. Both TRPV4 and NOX4 are activated by phosphatidylinositol 3-kinase (PI3K) downstream of TGFβ1, and signals from both TRPV4 and Rac are necessary for NOX4 upregulation. Notably, NOX4 expression is higher in fibroblasts derived from asthmatic patients (disease human LF; DHLF) in comparison to non-asthmatics (normal human LF; NHLF). Further, NOX4 expression is up-regulated in the lungs of D.farinae-treated wild type mice (WT) relative to saline-treated WT, which was attenuated in TRPV4 knockout (KO) mice. Our findings suggest that TRPV4 integrates TGFβ1 and ROS signaling through NOX4 and, TRPV4-NOX4 interaction is amenable to target lung remodeling during asthma.

Indexed as

Airway RemodelingCell DifferentiationAnimalsFibroblastsGene Expression RegulationGene Knockout TechniquesHumansMiceNADPH Oxidase 4Oxidation-ReductionPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesSignal TransductionTRPV Cation ChannelsNADPH Oxidase 4Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesTRPV4 protein, humanTRPV Cation Channels

Identifiers

PMID32555397
PMCPMC7299963
OpenAlexW3036162149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.